Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine and Venetoclax Maintenance Therapy Post-Transplant in Myeloid Malignancies
NCT06129734Phase 2Recruiting
- Start
- Jul 2025
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of venetoclax, decitabine in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS). Started Jul 2025; status: recruiting.
02
Drugs
venetoclaxdecitabine
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT06129734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06129734.